The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
The US Food and Drug Administration on Monday informed patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes.
World News
GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment
A large study suggests people with type 2 diabetes who start and then stop GLP-1 drugs may have poorer health outcomes, but more research is needed.
Every year, British interior designer Nicky Haslam – once called “the most stylish man in the world” – releases his damning list. You can write one too.
Every year, British interior designer Nicky Haslam – once called “the most stylish man in the world” – releases his damning list. You can write one too.
World News
SunRice CEO Paul Serra is determined to make rice more appealing to the wave of consumers taking weight-loss drugs.